| Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ... Jama 321 (2), 175-187, 2019 | 462 | 2019 |
| Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016 | 395 | 2016 |
| Amantadine for fatigue in multiple sclerosis E Pucci, PB Tato, R D'Amico, G Giuliani, A Solari, C Taus Cochrane database of systematic reviews, 2007 | 254* | 2007 |
| Migraine with aura and reproductive life events: a case control study F Granella, G Sances, E Pucci, RE Nappi, N Ghiotto, G Nappi Cephalalgia 20 (8), 701-707, 2000 | 248 | 2000 |
| Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ... Annals of neurology 80 (1), 89-100, 2016 | 206 | 2016 |
| Defining reliable disability outcomes in multiple sclerosis T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ... Brain 138 (11), 3287-3298, 2015 | 202 | 2015 |
| Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ... Annals of Neurology 77 (3), 425-435, 2015 | 187 | 2015 |
| Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial A Solari, A Motta, L Mendozzi, E Pucci, M Forni, G Mancardi, C Pozzilli Journal of the neurological sciences 222 (1-2), 99-104, 2004 | 185 | 2004 |
| Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ... The Lancet Neurology 16 (4), 271-281, 2017 | 171 | 2017 |
| Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches G Sances, C Tassorelli, E Pucci, N Ghiotto, G Sandrini, G Nappi Cephalalgia 24 (2), 110-119, 2004 | 153 | 2004 |
| Comparative study with EMG, pressure algometry and manual palpation in tension‐type headache and migraine G Sandrini, F Antonaci, E Pucci, G Bono, G Nappi Cephalalgia 14 (6), 451-457, 1994 | 152 | 1994 |
| The effect of intranasal cocaine and lidocaine on nitroglycerin‐induced attacks in cluster headache A Costa, E Pucci, F Antonaci, G Sances, F Granella, G Broich, G Nappi Cephalalgia 20 (2), 85-91, 2000 | 151 | 2000 |
| Natalizumab for relapsing remitting multiple sclerosis E Pucci, G Giuliani, A Solari, S Simi, S Minozzi, C Di Pietrantonj, I Galea Cochrane Database of Systematic Reviews, 2011 | 144 | 2011 |
| EEG spectral analysis in vascular and Alzheimer dementia M Signorino, E Pucci, N Belardinelli, G Nolfe, F Angeleri Electroencephalography and clinical neurophysiology 94 (5), 313-325, 1995 | 133 | 1995 |
| Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis A He, T Spelman, V Jokubaitis, E Havrdova, D Horakova, M Trojano, ... JAMA neurology 72 (4), 405-413, 2015 | 129 | 2015 |
| Towards personalized therapy for multiple sclerosis: prediction of individual treatment response T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ... Brain 140 (9), 2426-2443, 2017 | 114 | 2017 |
| Aminopyridines for symptomatic treatment in multiple sclerosis A Solari, BMJ Uitdehaag, G Giuliani, E Pucci, C Taus, ... Cochrane Database of Systematic Reviews 2010 (1), 1996 | 111 | 1996 |
| Communicating the diagnosis of multiple sclerosis-a qualitative study A Solari, N Acquarone, E Pucci, V Martinelli, MG Marrosu, M Trojano, ... Multiple Sclerosis Journal 13 (6), 763-769, 2007 | 105 | 2007 |
| Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study I Kister, T Spelman, R Alroughani, J Lechner-Scott, P Duquette, ... J Neurol Neurosurg Psychiatry 87 (10), 1133-1137, 2016 | 104 | 2016 |
| Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis C Tao, S Simpson, I Van Der Mei, L Blizzard, E Havrdova, D Horakova, ... J Neurol Neurosurg Psychiatry 87 (12), 1343-1349, 2016 | 98 | 2016 |
